Cingulate Inc.(CING)

Biotechnology · Kansas City, KS

$4.750.00 (0.00%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

Cingulate (CING) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T13:36:04.316Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:04.316Z.

Quote observation: 2026-10-06T13:35:02.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 4.76
Unrounded diluted TTM EPS · period ending 2026-06-30: -5.01

FMP input reference: f1b6469add1457cabf137e6e5cfb012e486d3d2c84b47330ed8a9effb8bf14c7

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CING PE Ratio Metrics

PE RATIO

N/A

CING Competitors' PE Ratio

CING

Cingulate Inc.

Current

Market Cap

$64.11M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs CING

Market Cap

$64.31M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs CING

Market Cap

$63.30M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALPS

Alps Group Inc

vs CING

Market Cap

$63.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs CING

Market Cap

$62.78M

PE Ratio

N/A

TTM Avg

14.25

3Y Avg

33.42

5Y Avg

30.04

GOSS

Gossamer Bio, Inc.

vs CING

Market Cap

$65.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs CING

Market Cap

$60.44M

PE Ratio

N/A

TTM Avg

110.41

3Y Avg

110.41

5Y Avg

110.41

INKT

MiNK Therapeutics, Inc.

vs CING

Market Cap

$60.48M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GUTS

Fractyl Health, Inc.

vs CING

Market Cap

$60.82M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CSBR

Champions Oncology, Inc.

vs CING

Market Cap

$68.91M

PE Ratio

N/A

TTM Avg

26.91

3Y Avg

41.68

5Y Avg

277.63

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Cingulate Inc. (CING)	$64.11M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$64.31M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$63.30M	N/A	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$63.23M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$62.78M	N/A	14.25	33.42	30.04
Gossamer Bio, Inc. (GOSS)vs ›	$65.69M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$60.44M	N/A	110.41	110.41	110.41
MiNK Therapeutics, Inc. (INKT)vs ›	$60.48M	N/A	N/A	N/A	N/A
Fractyl Health, Inc. (GUTS)vs ›	$60.82M	N/A	N/A	N/A	N/A
Champions Oncology, Inc. (CSBR)vs ›	$68.91M	N/A	26.91	41.68	277.63

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$4.76

Forward EPS (Est.)

$-2.13

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CING PE Ratio Metrics

CING Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics